- Home
- HIT vs FORA Comparison
HIT vs FORA Comparison
Compare HIT & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIT | FORA |
|---|---|---|
| Founded | 1964 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.4M | 69.4M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | HIT | FORA |
|---|---|---|
| Price | $1.46 | $2.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 632.5K | 28.7K |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $30,723,490.00 | $28,106,911.00 |
| Revenue This Year | $70.02 | $47.82 |
| Revenue Next Year | $44.08 | $10.11 |
| P/E Ratio | $68.55 | ★ N/A |
| Revenue Growth | ★ 55.15 | 37.47 |
| 52 Week Low | $0.51 | $1.64 |
| 52 Week High | $7.59 | $4.03 |
Technical Indicators
Market Signals| Indicator | HIT | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 44.36 |
| Support Level | $1.24 | $2.04 |
| Resistance Level | $1.46 | $2.18 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 87.76 | 42.19 |
Price Performance
Historical ComparisonAbout HIT Health In Tech Inc.
Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.